American Portfolios Advisors Amgen Inc Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Amgen Inc stock. As of the latest transaction made, American Portfolios Advisors holds 13,887 shares of AMGN stock, worth $4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
13,887
Holding current value
$4 Million
% of portfolio
0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$224.46 - $253.15 $3.12 Million - $3.52 Million
13,887 New
13,887 $3.13 Billion
Q2 2022

Mar 20, 2023
SELL
$230.71 - $256.74 $964,598 - $1.07 Million
-4,181 Reduced 30.11%
9,706 $2.36 Billion
Q1 2022

Mar 21, 2023
SELL
$219.27 - $242.57 $747,491 - $826,921
-3,409 Reduced 24.55%
10,478 $2.53 Billion
Q4 2021

Mar 21, 2023
SELL
$198.88 - $227.6 $1.12 Million - $1.28 Million
-5,637 Reduced 40.59%
8,250 $1.86 Billion
Q3 2021

Mar 22, 2023
SELL
$212.27 - $248.7 $1.29 Million - $1.51 Million
-6,056 Reduced 43.61%
7,831 $1.67 Billion
Q2 2021

Mar 22, 2023
SELL
$233.58 - $259.14 $1.49 Million - $1.65 Million
-6,385 Reduced 45.98%
7,502 $1.83 Billion
Q1 2021

Mar 22, 2023
SELL
$221.91 - $258.6 $1.6 Million - $1.86 Million
-7,198 Reduced 51.83%
6,689 $1.66 Billion
Q4 2020

Mar 22, 2023
SELL
$216.38 - $257.67 $1.77 Million - $2.11 Million
-8,183 Reduced 58.93%
5,704 $1.31 Billion
Q3 2020

Mar 22, 2023
SELL
$234.65 - $260.95 $1.88 Million - $2.09 Million
-8,001 Reduced 57.62%
5,886 $1.5 Billion
Q2 2020

Mar 24, 2023
BUY
$197.81 - $242.74 $1,978 - $2,427
10 Added 0.16%
6,134 $1.45 Billion
Q1 2020

Mar 24, 2023
SELL
$182.24 - $241.7 $1.41 Million - $1.88 Million
-7,763 Reduced 55.9%
6,124 $1.24 Billion
Q4 2019

Mar 24, 2023
SELL
$189.21 - $243.2 $1.39 Million - $1.78 Million
-7,337 Reduced 52.83%
6,550 $1.58 Billion
Q3 2019

Mar 24, 2023
SELL
$174.11 - $208.62 $5,919 - $7,093
-34 Reduced 0.48%
7,029 $1.36 Billion
Q2 2019

Mar 24, 2023
SELL
$166.7 - $195.41 $1.14 Million - $1.33 Million
-6,824 Reduced 49.14%
7,063 $1.3 Billion
Q1 2019

Mar 24, 2023
BUY
$180.87 - $203.88 $196,243 - $221,209
1,085 Added 21.23%
6,196 $1.18 Billion
Q4 2018

Mar 24, 2023
SELL
$178.4 - $208.25 $83,134 - $97,044
-466 Reduced 8.36%
5,111 $995 Million
Q3 2018

Mar 24, 2023
SELL
$185.29 - $208.89 $1.54 Million - $1.74 Million
-8,310 Reduced 59.84%
5,577 $1.16 Billion
Q2 2018

Mar 24, 2023
BUY
$166.05 - $186.51 $37,693 - $42,337
227 Added 4.21%
5,613 $1.04 Billion
Q1 2018

Mar 24, 2023
SELL
$169.43 - $198.0 $1.44 Million - $1.68 Million
-8,501 Reduced 61.22%
5,386 $918 Million
Q4 2017

Mar 24, 2023
SELL
$168.79 - $188.59 $1.76 Million - $1.96 Million
-10,418
3,469 $603 Million

Others Institutions Holding AMGN

# of Institutions
3,121
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email